IOL Chemicals & Pharmaceuticals Ltd has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company’s Pharmaceuticals API products ‘IBUPROFEN and ‘FENOFIBRATE’. The approval of Korean FDA re-establishes the Company’s efforts to…
IOL Chemicals & Pharmaceuticals Ltd receives Korean FDA approval – Equity Bulls
Share this article
More News
Brazil’s finance minister delays divisive crypto tax plan
March 23, 2026
Crypto tax reform in Brazil pushed to 2027
March 23, 2026
Why manual crypto trading is becoming obsolete
March 23, 2026